Therapeutic Targeting of Constitutive PARP Activation Compromises Stem Cell Phenotype and Survival of Glioblastoma-Initiating Cells

Cell Death and Differentiation - United Kingdom
doi 10.1038/cdd.2013.136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting PTPRZ Inhibits Stem Cell-Like Properties and Tumorigenicity in Glioblastoma Cells

Scientific Reports
Multidisciplinary
2017English

Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications

Cancers
Cancer ResearchOncology
2011English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

Radiosensitization of Glioblastoma Stem Cells Through Targeting Metabolic Reprogramming

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Cornering Metastases: Therapeutic Targeting of Circulating Tumor Cells and Stem Cells

Frontiers in Oncology
Cancer ResearchOncology
2012English

Corrigendum: Therapeutic Targeting of a Stem Cell Niche

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2008English

Therapeutic Strategies for Targeting Cancer Stem Cells

Journal of Cancer Metastasis and Treatment
2016English

Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

miR-186 Reverses Cisplatin Resistance and Inhibits The�formation of the Glioblastoma-Initiating Cell�phenotype by Degrading Yin Yang 1 in Glioblastoma

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy